| Literature DB >> 33634825 |
Heather A Baker1, Jonathan P Bernardini1,2,3.
Abstract
The accumulation of misfolded proteins is associated with numerous degenerative conditions, cancers and genetic diseases. These pathological imbalances in protein homeostasis (termed proteostasis), result from the improper triage and disposal of damaged and defective proteins from the cell. The ubiquitin-proteasome system is a key pathway for the molecular control of misfolded cytosolic proteins, co-opting a cascade of ubiquitin ligases to direct terminally damaged proteins to the proteasome via modification with chains of the small protein, ubiquitin. Despite the evidence for ubiquitination in this critical pathway, the precise complement of ubiquitin ligases and deubiquitinases that modulate this process remains under investigation. Whilst chaperones act as the first line of defence against protein misfolding, the ubiquitination machinery has a pivotal role in targeting terminally defunct cytosolic proteins for destruction. Recent work points to a complex assemblage of chaperones, ubiquitination machinery and subcellular quarantine as components of the cellular arsenal against proteinopathies. In this review, we examine the contribution of these pathways and cellular compartments to the maintenance of the cytosolic proteome. Here we will particularly focus on the ubiquitin code and the critical enzymes which regulate misfolded proteins in the cytosol, the molecular point of origin for many neurodegenerative and genetic diseases.Entities:
Keywords: cytosolic proteins; molecular chaperones; protein misfolding; protein quality control; ubiquitin; ubiquitin proteasome system
Mesh:
Substances:
Year: 2021 PMID: 33634825 PMCID: PMC7924994 DOI: 10.1042/BST20200694
Source DB: PubMed Journal: Biochem Soc Trans ISSN: 0300-5127 Impact factor: 5.407
Overview of key components found to be involved in cytosolic protein quality control and corresponding disease-associated mutations
| Protein | Pathological condition | Genetic mutation | Molecular mechanism | References |
|---|---|---|---|---|
| Cerebellar Ataxia | Various missense mutations and truncations | Mutations in CHIP's catalytic U-box domain or TPR binding domain result in impaired function | [ | |
| Episodic Ataxia | R5091H missense mutation, transcriptionally down-regulated | Mutation in C-terminal end of protein associated with familial ataxia, transcriptional down-regulation in Hirschsprung disease | [ | |
| Say–Meyer syndrome | Splice variant | Mutations in highly conserved regions of the gene, likely critical to function | [ | |
| Machado–Joseph disease | Poly-Q expansions | Poly-Q expansions result in the misfolding of Ataxin-3 | [ | |
| Alzheimer's disease | Various single nucleotide polymorphisms | Ubiquilin-1 mutation associated with familial Alzheimer's disease, disputed in literature | [ | |
| ALS, Frontotemporal dementia | Various missense mutations | Mutations in | [ | |
| ALS, Paget's Disease (IBMPFD) | Various missense mutations | Multiple missense mutations spanning multiple exons in conserved regions of VCP | [ |
Figure 1.Schematic representation of the molecular fates and key enzymatic regulators of misfolded proteins.
Chaperones (green) and ubiquitin ligases (orange) act in concert to refold or destroy misfolded proteins. In some contexts, misfolded cytosolic proteins may form inclusions either as phase separated compartments or insoluble aggregates. The cross-talk between these two states remains largely unknown.